Samsung, The New York Times, Dentsu and Harel all invested in the audience engagement platform developer in a round valuing it at $1bn.

Kindred Ventures led the healthcare services provider's series E round, valuing it at $4.6bn.

Kindred Ventures led the LeFrak-backed healthcare services provider's series E round valuing it at $4.6bn.

Bristol Myers Squibb and Pfizer Ventures are part of a PIPE financing backing the fibrosis and neurodegenerative disease drug developer's reverse takeover.

Glico and Physician Partners helped health test provider Viome raise $54m while real estate data provider CompStak and battery swapping technology developer Ample each bagged $50m.

The medical data aggregator increased its overall funding from $95m to $200m and has secured three new health system patners.

Deep Nishar has departed from his SBIA senior managing partner role to help develop enterprise software, biotech and life sciences pipelines at the venture firm.

Microsoft and Axa both returned for the cybersecurity technology provider’s latest round, taking its overall funding to $272m.

The Tegan and Circle K-backed mobile lottery ticket platform developer secured series D capital from investors including the Panasonic-financed Conductive Ventures.

Alexandria Venture Investments was among the participants in a series B round which will support clinical trials for Acrivon's lead oncology drug candidate.